Glycogen storage disease type IV, abbreviated GSD IV, is a form of glycogen storage disease caused by an inborn error of metabolism. It results from a mutation in the GBE1 gene, which causes a defect in the glycogen branching enzyme, so glycogen is not made properly and abnormal glycogen molecules called polyglucosan accumulate in cells, possibly in the liver, skeletal muscle, heart or nervous system. It is autosomal recessive. An early-onset form is called Andersen disease and an adult-onset form is called adult polyglucosan body disease. GSD IV is estimated to affect about 1 in 236,000 people worldwide, about 3 percent of all glycogen storage diseases.
Facts
Classification
ICD-10 ChapterIV: Endocrine, Nutritional and Metabolic Diseases 1 Communicable or Non-communicable Causative Agent
Causative Agent (category) Prevalence Band Sources
1. Glycogen storage disease type IV (Wikipedia)
Lead, first sentence
which is caused by an inborn error of metabolism
Lead, second sentence
It is the result of a mutation in the GBE1 gene
View the Source2. National Cancer Institute (NCI Thesaurus): Glycogen storage disease type IV - NCI Thesaurus concept C84737
National Cancer Institute (NCI Thesaurus)DefinitionQuote, Definition
A rare inherited type of glycogen storage disease caused by deficiency of amylo-1,4-1,6 transglucosidase.
View the Source 3. Orphadata (Orphanet): Orphadata epidemiology for ORPHA:367 Glycogen storage disease due to glycogen branching enzyme deficiency
Orphadata (Orphanet)Prevalence, WorldwideQuote, Prevalence, Worldwide
"PrevalenceClass": "1-9 / 1 000 000", "PrevalenceGeographic": "Worldwide"
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.